The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.

Osman, Janina

The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer. [electronic resource] - Anticancer research Apr 2019 - 1719-1728 p. digital

Publication Type: Journal Article

1791-7530

10.21873/anticanres.13278 doi


Aldehyde Dehydrogenase--genetics
Aldehyde Dehydrogenase 1 Family
Animals
Antineoplastic Agents--pharmacology
Basic Helix-Loop-Helix Transcription Factors--metabolism
Caco-2 Cells
Colonic Neoplasms--drug therapy
Cyclooxygenase 2--metabolism
Dinoprostone--metabolism
Doublecortin-Like Kinases
Female
HT29 Cells
Humans
Hydroxyprostaglandin Dehydrogenases--metabolism
Intracellular Signaling Peptides and Proteins--genetics
Mice, Inbred BALB C
Mice, Nude
Neoplastic Stem Cells--drug effects
Oligopeptides--pharmacology
Protein Serine-Threonine Kinases--genetics
Retinal Dehydrogenase
Tumor Burden--drug effects
Tumor Microenvironment
Wnt Signaling Pathway--drug effects
Wnt-5a Protein--agonists
Xenograft Model Antitumor Assays
beta Catenin--metabolism